 effect cyclosporin hear loss behcet diseas thirty-f patient behcet diseas cyclosporin cya treatment convent therapi patient endogen uveiti normal subject studi year twenty-eight behcet patient degre hear loss averag pure tone audiogram behcet group signific auditori deficit comparison control group none behcet group uveiti group hear deterior follow-up period patient cya therapi improv hear differ group behcet patient cya versu convent treatment signific cya import mode treatment sensorineur hear loss inflammatori autoimmun background